TranS1 Reports 32% Fall in 3Q Revenues

TranS1 has reported third-quarter revenues of $3.2 million, a 32 percent decreased compared to the same period last year.

Advertisement

The spine device company also saw declines in domestic revenues and gross margin and an increase in net losses.

More Articles on Orthopedic Devices:

DePuy Launches New Trumatch Pin for Orthopedic Implants

Investors Increase Stake in Smith & Nephew

Titan Spine Appoints Marcus Klarl Vice President of Sales

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.